Keyphrases
Traumatic Intracranial Hemorrhage
100%
Antiplatelet Agents
100%
Anticoagulant Agents
100%
Ground-level Fall
100%
Intracranial Hemorrhage
100%
Confidence Interval
60%
Aspirin
50%
Anticoagulants
40%
Computed Tomography Head
30%
Head Trauma
30%
Warfarin
30%
Antiplatelet Drugs
30%
Antiplatelet
30%
Anticoagulant Medications
30%
Injury Mechanism
20%
Prospective Cohort Study
10%
Clinically Significant
10%
Emergency Department
10%
Low Incidence
10%
Consecutive Patients
10%
Inclusion Criteria
10%
Tertiary Care
10%
Minor Head Trauma
10%
Enoxaparin
10%
Bleeding
10%
Trauma Center
10%
Rehabilitation Centers
10%
Low Acuity
10%
Hospital Course
10%
Dabigatran
10%
Prasugrel
10%
Hemorrhage Rate
10%
Ticagrelor
10%
Apixaban
10%
Trauma Registry
10%
Craniotomy
10%
Direct Oral Anticoagulants
10%
Chart Review
10%
Electronic Screening
10%
Rivaroxaban
10%
Heterogeneous Mechanism
10%
Nursing and Health Professions
Antithrombocytic Agent
100%
Brain Hemorrhage
100%
Anticoagulant Agent
100%
Confidence Interval
54%
Head Injury
36%
Injury
27%
Drug Therapy
27%
Warfarin
27%
Computer Assisted Tomography
27%
Triage
9%
Clinician
9%
Rehabilitation Engineering
9%
Emergency Ward
9%
Tertiary Health Care
9%
Prospective Cohort Study
9%
Enoxaparin
9%
Apixaban
9%
Rivaroxaban
9%
Low Drug Dose
9%
Dabigatran
9%
Prasugrel
9%
Craniotomy
9%
Ticagrelor
9%
Pharmacology, Toxicology and Pharmaceutical Science
Anticoagulant Agent
100%
Brain Hemorrhage
100%
Antithrombocytic Agent
100%
Antiplatelet
54%
Acetylsalicylic Acid
45%
Injury
36%
Head Injury
36%
Warfarin
27%
Prasugrel
9%
Rivaroxaban
9%
Prospective Cohort Study
9%
Direct Oral Anticoagulant
9%
Apixaban
9%
Ticagrelor
9%
Enoxaparin
9%
Dabigatran
9%
Neuroscience
Antiplatelet Drug
100%
Antithrombotic
100%
Cerebral Hemorrhage
100%
Aspirin
45%
Closed Head Injury
36%
Computed Tomography
27%
Warfarin
27%
Anticoagulant
27%
Craniotomy
9%
Prasugrel
9%
Dabigatran
9%
Ticagrelor
9%
Rivaroxaban
9%
Apixaban
9%